Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
A 44-year-old woman is described with an endocrine tumour arising in the kidney. There were associated abnormalities of small intestinal morphology, motility, and absorptive function. These abnormalities reversed on removal of the tumour. Detailed studies showed that the tumour contained, and was secreting, glucagon. It is postulated that the intestinal abnormalities may have resulted from glucagon itself or another, as yet unidentified, hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAPID METHOD FOR THE DETERMINATION OF FAT IN FECES
van de Kamer, J. H., Huinink, H. T. B., & Weyers, H. A. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57092-7 · Cited by 1,845
PEARSE, A. G. E. (1969) · Journal of Histochemistry & Cytochemistry · doi:10.1177/17.5.303 · Cited by 1,673
STUDIES ON ANTIBODY PRODUCTION
Coons, A. H., Leduc, E. H., & Connolly, J. M. (1955) · The Journal of Experimental Medicine · doi:10.1084/jem.102.1.49 · Cited by 1,555
Structural and functional changes following small intestinal resection in the rat.
Rh, D., & Cc, B. (1967) · PubMed · Cited by 474
Schilling, R. F. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.09.001 · Cited by 440
A Glucagon-Secreting Alpha-Cell Carcinoma of the Pancreas
McGavran, M. H., Unger, R. H., Recant, L., Polk, H. C., Kilo, C., & Levin, M. E. (1966) · New England Journal of Medicine · doi:10.1056/nejm196606232742503 · Cited by 352
Influence of Glucagon on Pancreatic Exocrine Secretion in Man
Dyck, W. P., Texter, E. C., Lasater, J., & Hightower, N. C. (1970) · Gastroenterology · doi:10.1016/s0016-5085(70)80067-1 · Cited by 152
Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog
Polak, J. M., Bloom, S., Coulling, I., & Pearse, A. G. E. (1971) · Gut · doi:10.1136/gut.12.4.311 · Cited by 135
Self-citationGASTRO-INTESTINAL STUDIES. VII. THE EXCRETION OF XYLOSE IN PERNICIOUS ANEMIA
Helmer, O. M., & Fouts, P. J. (1937) · Journal of Clinical Investigation · doi:10.1172/jci100862 · Cited by 72
Inhibition of Intestinal Motility in Man by Glucagon Given Intraportally
Kock, N. G., Dakle, N., & Dotevall, G. (1967) · Gastroenterology · doi:10.1016/s0016-5085(19)34266-0 · Cited by 63
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22555 · Cited by 532
Biological actions and therapeutic potential of the glucagon-like peptides
Drucker, D. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.31068 · Cited by 500
Minireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/en.142.2.521 · Cited by 421
Feldman, E. J., Dowling, R. H., McNaughton, J., & Peters, T. J. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80261-2 · Cited by 358
Self-citationIntestinal growth-promoting properties of glucagon-like peptide-2 in mice
Tsai, C. H., Hill, M., Asa, S. L., Brubaker, P. L., & Drucker, D. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e77 · Cited by 319
Benjamin, M. A., McKay, D. M., Yang, P.-C., Cameron, H., & Perdue, M. H. (2000) · Gut · doi:10.1136/gut.47.1.112 · Cited by 277
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
Drucker, D. J., Shi, Q., Crivici, A., Sumner-Smith, M., Tavares, W., Hill, M., DeForest, L., Cooper, S., & Brubaker, P. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-673 · Cited by 276
Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
Xiao, Q., Boushey, R. P., Cino, M., Drucker, D. J., & Brubaker, P. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r1057 · Cited by 111
“The findings that intestinal injury in rodents and humans is commonly associated with increased levels of the gut proglucagonderived peptides (PGDPs; 1), taken together with observations of gut growth in patients with glucagonproducing tumors (14, 26), ultimately led to the identification of one of the PGDPs, GLP-2, a…”
BackgroundA familial glucagonoma syndrome
Stacpoole, P. W., Jaspan, J., Kasselberg, A. G., Halter, S. A., Polonsky, K., Gluck, F. W., Liljenquist, J. E., & Rabin, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90858-5 · Cited by 42
Metadata
- Authors
- Gleeson, M. H., Bloom, S. R., Polak, J. M., Henry, K., & Dowling, R. H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1971-10
- Volume
- 12
- Issue
- 10
- Pages
- 773-782
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2133396569
- Cited by
- 381
- References
- 13
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.